Impact of choice of inhalers for asthma care on global carbon footprint and societal costs: a long-term economic evaluation

References

• Global Asthma Network. The global asthma report. 2018. Available from: http://globalasthmareport.org/resources/Global_Asthma_Report_2018.pdf.
   Google Scholar
• Lee LK, Obi E, Paknis B, et al. Asthma control and disease burden in patients with asthma and allergic comorbidities. Journal of Asthma. 2018;55(2):208–219.
   PubMed Web of Science ®Google Scholar
• National Health Society. Long term plan. 2019. Available from: https://www.longtermplan.nhs.uk/wp-content/uploads/2019/08/nhs-long-term-plan-version-1.2.pdf.
   Google Scholar
• National Institute for Health and Care Excellence. Patient decision aid: inhalers for asthma. 2020. Available from: https://www.nice.org.uk/guidance/ng80/resources/inhalers-for-asthma-patient-decision-aid-pdf-6727144573.
   Google Scholar
• Lavorini F, Corrigan CJ, Barnes PJ, et al. Retail sales of inhalation devices in European countries: so much for a global policy. Respir Med. 2011;105(7):1099–1103.
   PubMed Web of Science ®Google Scholar
• Janson C, Henderson R, Löfdahl M, et al. Carbon footprint impact of the choice of inhalers for asthma and COPD. Thorax. 2020;75(1):82–84.
   PubMed Web of Science ®Google Scholar
• Myrdal PB, Sheth P, Stein SW. Advances in metered dose inhaler technology: formulation development. AAPS PharmSciTech. 2014;15(2):434–455.
   PubMed Web of Science ®Google Scholar
• Greenhouse Gas Protocol. Global warming potential values. Available from: https://www.ghgprotocol.org/sites/default/files/ghgp/Global-Warming-Potential-Values%20%28Feb%2016%202016%29_1.pdf.
   Google Scholar
• Myhre G, Shindell D, Bréon FM, et al. Anthropogenic and natural radiative forcing. In: Stocker TF, Qin D, Plattner GK, Tignor M, Allen SK, Boschung J, Nauels A, Xia Y, Bex V, Midgley PM, editors, Climate change 2013: the physical science basis. Contribution of working group I to the fifth assessment report of the intergovernmental panel on climate change. Cambridge, United Kingdom and New York, United States: Cambridge University Press; 2013.
   Google Scholar
• Ortsäter G, Borgström F, Soulard S, et al. A budget impact model to estimate the environmental impact of adopting RESPIMAT® re-usable in the Nordics and Benelux. Adv Ther. 2019;36(12):3435–3445.
   PubMed Web of Science ®Google Scholar
• Ozone Secretariat UN Environment Programme. Medical and Chemicals Technical Options Committee 2018 assessment report. 2018. Available from: https://ozone.unep.org/sites/default/files/2019-04/MCTOC-Assessment-Report-2018.pdf.
   Google Scholar
• Ozone Secretariat UN Environment Programme. Handbook for the Montreal protocol on substances that deplete the ozone layer. Nairobi (Kenya): Ozone Secretariat UN Environment Programme; 2020.
   Google Scholar
• European Environment Agency. Fluorinated greenhouse gases 2019. 2019. Available from: https://www.eea.europa.eu/publications/fluorinated-greenhouse-gases-2019.
   Google Scholar
• Environmental Protection Agency. Phasedown of hydrofluorocarbons: establishing the allowance allocation and trading program under the American Innovation and Manufacturing Act. 2021. Available from: https://www.govinfo.gov/content/pkg/FR-2021-05-19/pdf/2021-09545.pdf.
   Google Scholar
• Pritchard JN. The climate is changing for metered-dose inhalers and action is needed. Drug Des Devel Ther. 2020;14:3043–3055.
   PubMed Web of Science ®Google Scholar
• Pernigotti D, Stonham C, Panigone S, et al. Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countries. BMJ Open Resp Res. 2021;8(1):e001071.
   PubMed Web of Science ®Google Scholar
• Sustainable Development Unit (Producer). Carbon hotspot: reducing inhalers. Available from: https://www.sduhealth.org.uk/documents/AboutUs/LTP%20comms/inhalers%20(2%20slides)%20v1.1.pptx.
   Google Scholar
• Global Initiative for Asthma. Asthma management and prevention for adults and children older than 5 years, a pocket guide for health professionals. 2019. Available from: https://ginasthma.org/wp-content/uploads/2019/04/GINA-2019-main-Pocket-Guide-wms.pdf.
   Google Scholar
• Wilkinson AJ, Braggins R, Steinbach I, et al. Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England. BMJ Open. 2019;9(10):e028763.
   PubMed Web of Science ®Google Scholar
• Hänsel M, Bambach T, Wachtel H. Reduced environmental impact of the reusable respimat® soft mist™ inhaler compared with pressurised metered-dose inhalers. Adv Ther. 2019;36(9):2487–2492.
   PubMed Web of Science ®Google Scholar
• IQVIA MIDAS Database. Global inhaler sales. 2020. Available from: https://www.iqvia.com/.
   Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention. 2021. Available from: https://ginasthma.org/wp-content/uploads/2021/05/GINA-Main-Report-2021-V2-WMS.pdf.
   Google Scholar
• British Thoracic Society/Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma – a national clinical guideline. 2019. Available from: https://www.sign.ac.uk/media/1773/sign158-updated.pdf.
   Google Scholar
• European FluoroCarbons Technical Committee. European pharmaceutical company announces low GWP HFC-152A Metered Dose Inhaler (MDI). 2020. Available from https://www.fluorocarbons.org/news/european-pharmaceutical-company-announces-low-gwp-hfc-152a-metered-dose-inhaler-mdi/.
   Google Scholar
• United Nations Department of Management Strategy, Policy and Compliance. 2019. United Nations Secretariat climate action plan 2020–2030. Available from: https://www.un.org/management/sites/www.un.org.management/files/united-nations-secretariat-climate-action-plan.pdf.
   Google Scholar
• The World Bank. World Bank Country and Lending Groups. 2020. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519.
   Google Scholar
• United Nations Department of Economic and Social Affairs – Population Division (2019). 2019. World population prospects 2019, online edition. Rev. 1. Available from: https://population.un.org/wpp/.
   Google Scholar
• Global Burden of Disease Collaborative Network. Global burden of disease study 2016 (GBD 2016) reference life table. 2017. Available from: https://ghdx.healthdata.org/record/ihme-data/gbd-2016-reference-life-table.
   Google Scholar
• United Nations Department of Economic and Social Affairs – Population Division (2019). 2019. World urbanization prospects: the 2018 revision. Available from: https://www.un.org/development/desa/publications/2018-revision-of-world-urbanization-prospects.html.
   Google Scholar
• The World Bank. GDP per capita, PPP (constant 2011 international $). Available from: https://databank.worldbank.org/source/jobs/Series/NY.GDP.PCAP.PP.KD.
   Google Scholar
• World Health Organization. Updated WHO projections of mortality and causes of death, 2016–2060. Available from https://www.who.int/healthinfo/global_burden_disease/projections_method.pdf?ua=1.
   Google Scholar
• United Nations Department of Economic and Social Affairs – Economic Analysis (2020). 2021. World economic situation and prospects. Available from: https://www.un.org/development/desa/dpad/wp-content/uploads/sites/45/WESP2020_FullReport.pdf
   Google Scholar
• US Food & Drug Administration. Orange book: approved drug products with therapeutic equivalence evaluations. Available from https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm.
   Google Scholar
• U.S. Government Interagency Working Group on Social Cost of Greenhouse Gases. Technical support document: social cost of carbon, methane, and nitrous oxide – interim estimates under executive order 13990. Available from: https://www.whitehouse.gov/wp-content/uploads/2021/02/TechnicalSupportDocument_SocialCostofCarbonMethaneNitrousOxide.pdf.
   Google Scholar
• Tang L, Ii R, Tokimatsu K, et al. Development of human health damage factors related to CO 2 emissions by considering future socioeconomic scenarios. Int J Life Cycle Assess. 2018;23(12):2288–2299.
   Web of Science ®Google Scholar
• IPCC. Summary for policy makers – emissions scenarios. 2000. Available from: https://www.ipcc.ch/site/assets/uploads/2018/03/sres-en.pdf.
   Google Scholar
• Ritchie H, Roser M. CO2 and greenhouse gas emissions. 2020. Published online at OurWorldInData.org. Available from: https://ourworldindata.org/co2-emissions.
   Google Scholar
• Wilkinson AJK, Anderson G. Sustainability in inhaled drug delivery. Pharmaceut Med. 2020;34(3):191–199.
   PubMed Web of Science ®Google Scholar
• Prevention CFDCA. Climate effects on health. 2021. Available from: https://www.cdc.gov/climateandhealth/effects/default.htm.
   Google Scholar
• Adachi Y, Adachi Y, Itazawa T, et al. Measurement of peak inspiratory flow rates with an in-check meter to identify preschool children's ability to use dry powder inhalers; diskus and turbuhaler. J Aller Clin Immunol. 2004;113(2):S114.
   Google Scholar
• Al-Showair RA, Tarsin WY, Assi KH, et al. Can all patients with COPD use the correct inhalation flow with all inhalers and does training help? Respirat Med. 2007;101(11):2395–2401.
   PubMed Web of Science ®Google Scholar
• Lavorini F. The challenge of delivering therapeutic aerosols to asthma patients. ISRN Allergy. 2013;2013:102418.
   PubMedGoogle Scholar
• Anand A, Palaksha S, P.a M. Prs63 comparison of clinical outcomes associated with different inhaler devices in asthma and COPD. Value Health. 2020;23:S360.
   Web of Science ®Google Scholar
• Kemp L, Haughney J, Barnes N, et al. Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: a real world observational study. Clinicoecon Outcomes Res. 2010;2:75–85.
   PubMedGoogle Scholar
• Morice AH, Peterson S, Beckman O, et al. Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma. Int J Clin Pract. 2007;61(11):1874–1883.
   PubMed Web of Science ®Google Scholar
• Ramadan WH, Sarkis AT. Patterns of use of dry powder inhalers versus pressurized metered-dose inhalers devices in adult patients with chronic obstructive pulmonary disease or asthma: an observational comparative study. Chron Respir Dis. 2017;14(3):309–320.
   PubMed Web of Science ®Google Scholar
• Rubin BK, Fink JB. Optimizing aerosol delivery by pressurized metered-dose inhalers. Respir Care. 2005;50(9):1191–1200.
   PubMedGoogle Scholar
• Azouz W, Campbell J, Stephenson J, et al. Improved metered dose inhaler technique when a coordination cap is used. J Aerosol Med Pulm Drug Deliv. 2014;27(3):193–199.
   PubMed Web of Science ®Google Scholar
• Tervonen T, Hawken N, Hanania NA, et al. Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment. Thorax. 2020;75(9):735–743.
   PubMed Web of Science ®Google Scholar
• Liew K, Wilkinson A. P280 How do we choose inhalers? Patient and physician perspectives on environemntal, financial and ease-of-use factors. Thorax. 2017;72:A235–A237.
   Web of Science ®Google Scholar
• Panigone S, Sandri F, Ferri R, et al. Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment. BMJ Open Resp Res. 2020;7(1):e000571.
   PubMed Web of Science ®Google Scholar
• Gerald JK. Generic competition for orally inhaled respiratory medications. Two steps forward, one step back. Ann Am Thorac Soc. 2017;14(2):165–167.
   PubMed Web of Science ®Google Scholar
• Woodcock A, Janson C, Rees J, et al. Effects of switching from a metered dose inhaler to a dry powder inhaler on climate emissions and asthma control: post-hoc analysis. Thorax. 2022. DOI:10.1136/thoraxjnl-2021-218088
   Web of Science ®Google Scholar
• Thomas M, Price D, Chrystyn H, et al. Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control. BMC Pulm Med. 2009;9:1.
   PubMedGoogle Scholar
• Ekberg-Jansson A, Svenningsson I, Rågdell P, et al. Budesonide inhaler device switch patterns in an asthma population in Swedish Clinical Practice (ASSURE). Int J Clin Pract. 2015;69(10):1171–1178.
   PubMed Web of Science ®Google Scholar
• Jeswani HK, Azapagic A. Life cycle environmental impacts of inhalers. J Cleaner Prod. 2019;237:117733.
   Web of Science ®Google Scholar
• IPCC. Climate change 2021: the physical science basis. Contribution of working group I to the sixth assessment report of the intergovernmental panel on climate change. Cambridge: Cambridge University Press; 2021.
   Google Scholar